EZZ Life Science Holdings (ASX:EZZ) COGS-to-Revenue : 0.29 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings COGS-to-Revenue?

EZZ Life Science Holdings's Cost of Goods Sold for the six months ended in Dec. 2023 was A$6.39 Mil. Its Revenue for the six months ended in Dec. 2023 was A$21.70 Mil.

EZZ Life Science Holdings's COGS to Revenue for the six months ended in Dec. 2023 was 0.29.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. EZZ Life Science Holdings's Gross Margin % for the six months ended in Dec. 2023 was 70.55%.

EZZ Life Science Holdings COGS-to-Revenue Historical Data

The historical data trend for EZZ Life Science Holdings's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings COGS-to-Revenue Chart

EZZ Life Science Holdings Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

COGS-to-Revenue

0.44

0.50

0.23

EZZ Life Science Holdings Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial			0.52	0.49	0.26	0.21	0.29

EZZ Life Science Holdings COGS-to-Revenue Calculation

EZZ Life Science Holdings's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	8.613	/	37.143
	=	0.23

EZZ Life Science Holdings's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6.389	/	21.697
	=	0.29

EZZ Life Science Holdings (ASX:EZZ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

EZZ Life Science Holdings's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	6.389 / 21.697
	=	70.55 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

EZZ Life Science Holdings COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

EZZ Life Science Holdings (ASX:EZZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

104 Derby Street, Silverwater, NSW, AUS, 2128

Website

https://www.ezzlife.com.au

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines